JP2024529975A5 - - Google Patents
Info
- Publication number
- JP2024529975A5 JP2024529975A5 JP2024505286A JP2024505286A JP2024529975A5 JP 2024529975 A5 JP2024529975 A5 JP 2024529975A5 JP 2024505286 A JP2024505286 A JP 2024505286A JP 2024505286 A JP2024505286 A JP 2024505286A JP 2024529975 A5 JP2024529975 A5 JP 2024529975A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163227972P | 2021-07-30 | 2021-07-30 | |
| US63/227,972 | 2021-07-30 | ||
| PCT/US2022/074337 WO2023010128A2 (en) | 2021-07-30 | 2022-07-29 | Rna vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024529975A JP2024529975A (ja) | 2024-08-14 |
| JP2024529975A5 true JP2024529975A5 (https=) | 2025-08-05 |
| JPWO2023010128A5 JPWO2023010128A5 (https=) | 2025-08-05 |
Family
ID=85088269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505286A Pending JP2024529975A (ja) | 2021-07-30 | 2022-07-29 | Ｒｎａワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230219996A1 (https=) |
| EP (1) | EP4376883A4 (https=) |
| JP (1) | JP2024529975A (https=) |
| KR (1) | KR20240050353A (https=) |
| CN (1) | CN118043068A (https=) |
| AR (1) | AR126625A1 (https=) |
| AU (1) | AU2022319940A1 (https=) |
| BR (1) | BR112024001911A2 (https=) |
| CA (1) | CA3226806A1 (https=) |
| CR (1) | CR20240095A (https=) |
| IL (1) | IL310107A (https=) |
| MX (1) | MX2024001464A (https=) |
| TW (1) | TW202313967A (https=) |
| WO (1) | WO2023010128A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021183563A1 (en) | 2020-03-09 | 2021-09-16 | Arcturus Therapeutics, Inc. | Coronavirus vaccine compositions and methods |
| US12178921B2 (en) | 2020-08-14 | 2024-12-31 | Arcturus Therapeutics, Inc. | Method of lyophilizing lipid nanoparticles |
| WO2024211625A1 (en) * | 2023-04-07 | 2024-10-10 | Arcturus Therapeutics, Inc. | Hbv gene editing |
| TW202539706A (zh) * | 2023-11-14 | 2025-10-16 | 大陸商上海瑞宏迪醫藥有限公司 | 一種脂質奈米粒的製備方法和應用 |
| WO2025166323A2 (en) | 2024-02-02 | 2025-08-07 | Editas Medicine, Inc. | Crispr-related methods and compositions targeting lipoprotein (a) expression |
| WO2025161942A1 (zh) * | 2024-02-02 | 2025-08-07 | 仁景(苏州)生物科技有限公司 | 用于递送的脂质化合物和脂质纳米颗粒 |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| CN121021427A (zh) * | 2024-07-30 | 2025-11-28 | 广州市恒诺康医药科技有限公司 | 可离子化脂质及其用途 |
| JP7657411B1 (ja) * | 2025-01-23 | 2025-04-07 | 医療法人すぎやま内科 | 乳がん細胞の増殖抑制剤及び乳がん治療剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014081507A1 (en) * | 2012-11-26 | 2014-05-30 | Moderna Therapeutics, Inc. | Terminally modified rna |
| KR20180074699A (ko) * | 2015-11-09 | 2018-07-03 | 이뮨 디자인 코포레이션 | 이종 핵산을 발현하는 rna 레플리콘의 발현 및 투여를 위한 레트로바이러스 벡터 |
| JP7788787B2 (ja) * | 2016-12-05 | 2025-12-19 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 遺伝子発現増強のための組成物および方法 |
| MA51523A (fr) * | 2018-01-05 | 2020-11-11 | Modernatx Inc | Polynucléotides codant pour des anticorps anti-virus du chikungunya |
| KR20210074314A (ko) * | 2018-10-08 | 2021-06-21 | 얀센 파마슈티칼즈, 인코포레이티드 | 생체치료제의 투여를 위한 알파바이러스 기반 레플리콘 |
| US11406699B2 (en) * | 2019-03-22 | 2022-08-09 | George Mason University | Alphavirus and compositions, methods, and kits related thereto |
| WO2020209929A1 (en) * | 2019-04-09 | 2020-10-15 | Massachusetts Institute Of Technology | Mutant subgenomic promoter library and uses thereof |
| US20220313813A1 (en) * | 2019-06-18 | 2022-10-06 | Curevac Ag | Rotavirus mrna vaccine |
| US20220313815A1 (en) * | 2019-06-20 | 2022-10-06 | Janssen Sciences Ireland Unlimited Company | Self-replicating rna molecules for hepatitis b virus (hbv) vaccines and uses thereof |
| KR20220115569A (ko) * | 2019-11-18 | 2022-08-17 | 얀센 바이오테크 인코포레이티드 | 돌연변이 calr 및 jak2에 기반한 백신 및 이의 용도 |
| US12194089B2 (en) * | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
| WO2021183563A1 (en) * | 2020-03-09 | 2021-09-16 | Arcturus Therapeutics, Inc. | Coronavirus vaccine compositions and methods |
| CA3170743A1 (en) * | 2020-08-31 | 2022-03-03 | Susanne RAUCH | Multivalent nucleic acid based coronavirus vaccines |
-
2022
- 2022-07-29 TW TW111128541A patent/TW202313967A/zh unknown
- 2022-07-29 EP EP22850552.5A patent/EP4376883A4/en active Pending
- 2022-07-29 WO PCT/US2022/074337 patent/WO2023010128A2/en not_active Ceased
- 2022-07-29 JP JP2024505286A patent/JP2024529975A/ja active Pending
- 2022-07-29 CN CN202280058353.XA patent/CN118043068A/zh active Pending
- 2022-07-29 KR KR1020247007128A patent/KR20240050353A/ko active Pending
- 2022-07-29 IL IL310107A patent/IL310107A/en unknown
- 2022-07-29 AU AU2022319940A patent/AU2022319940A1/en active Pending
- 2022-07-29 MX MX2024001464A patent/MX2024001464A/es unknown
- 2022-07-29 US US17/816,243 patent/US20230219996A1/en active Pending
- 2022-07-29 BR BR112024001911A patent/BR112024001911A2/pt unknown
- 2022-07-29 CA CA3226806A patent/CA3226806A1/en active Pending
- 2022-07-29 CR CR20240095A patent/CR20240095A/es unknown
- 2022-07-29 AR ARP220102043A patent/AR126625A1/es unknown